Physical Activity Intervention for Cognitive Function Post-Stem Cell Transplant
(PROACTIVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if increasing physical activity can enhance thinking and memory in older adults who have undergone a stem cell transplant for blood cancer. Participants will engage in a specially adapted exercise program (CHAMPS-II, tailored for adults aged 60 and older in an HCT setting) to assess its impact on cognitive function. The study also examines how Alzheimer's disease factors and inflammation may influence memory issues related to cancer treatments. This trial is ideal for individuals aged 55 and older who have had a stem cell transplant in the past 3 to 6 months and can walk a short distance. As an unphased trial, it offers a unique opportunity to contribute to understanding the benefits of exercise on cognitive health post-transplant.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this physical activity intervention is safe for older adults post-stem cell transplant?
Studies have shown that the CHAMPS-II physical activity program is generally well-tolerated by older adults. This program allows seniors to choose their own physical activities, making it flexible and easier to follow. Although specific data on side effects for this version in the HCT setting is unavailable, older people have safely used the original CHAMPS-II program. This suggests that the adapted program could also be safe. Overall, programs like this have a good safety record for seniors.12345
Why are researchers excited about this trial?
Researchers are excited about the adapted CHAMPS-II physical activity program because it focuses on enhancing cognitive function for adults over 60 who have undergone stem cell transplants. Unlike traditional cognitive therapies that might rely on medication or cognitive exercises alone, this intervention incorporates physical activity tailored to the unique needs of this group. The program is not only expected to improve cognitive outcomes but also engages the patients' care-partners and healthcare team, providing a holistic approach to recovery and feedback. This comprehensive and interactive method has the potential to offer a more engaging and effective path to cognitive recovery compared to existing options.
What evidence suggests that the adapted CHAMPS-II intervention is effective for improving cognitive function post-stem cell transplant?
Research shows that exercise can boost brain function in older adults, including cancer survivors. Early data indicates that after a stem cell transplant, 35% of older patients face serious memory and thinking issues, compared to 19% before the transplant. In this trial, the CHAMPS-II program, a physical activity plan aimed at improving memory and thinking skills in seniors, has been specially adapted for older adults who have undergone hematopoietic cell transplantation (HCT). Initial studies suggest that increased activity can help reduce memory and thinking problems in this group, possibly enhancing their quality of life. Participants in this trial will either receive the adapted CHAMPS-II intervention immediately or after a wait period, allowing researchers to assess its effectiveness.12678
Who Is on the Research Team?
Thuy Koll, MD
Principal Investigator
University of Nebraska
Are You a Good Fit for This Trial?
This trial is for older adults aged 60+ who have hematological malignancies like lymphoma or leukemia and are undergoing stem cell transplant. They must be able to walk a short distance, speak English, and consent to participate. Care-partners of these patients can also join if they meet similar criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preliminary Adaptation
Participants provide feedback on the CHAMPS-II intervention and survivorship education materials through qualitative interviews.
Treatment
Participants engage in the adapted CHAMPS-II physical activity program to improve cognitive function.
Follow-up
Participants are monitored for changes in cognitive function and physical activity outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- CHAMPS-II adapted to adults 60+ years in HCT setting
- Survivorship education active control
Trial Overview
The trial tests an adapted physical activity program called CHAMPS-II, designed to improve cognitive function in seniors post-stem cell transplant. Participants will engage in light to moderate exercises until Day 100 post-transplant compared with a wait-list control group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
All participants in Aim 2 (preliminary testing) and Aim 3 (RCT) will participate in the CHAMPS-II physical activity program adapted to the HCT setting. Testing for outcome measures will be completed, and feedback on the intervention will be obtained via qualitative interviews from 1)adult participants 60+ years receiving HCT, 2)participants' care-partner, and 3)HCT team members. Aim 3 participants will be randomized to either the immediate intervention (intervention then follow-up) or delayed intervention (wait period and then intervention).
Participants in Aim 1 will participate in qualitative interviews to obtain feedback on the CHAMPS-II intervention and survivorship education active control condition materials. Interviews will be with 1)adult participants 60+ years who have recently undergone HCT, 2)participants' care-partner, and 3)HCT team members.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thuy Koll MD
Lead Sponsor
University of Nebraska
Lead Sponsor
Published Research Related to This Trial
Citations
Promoting Physical Activity to Improve Cognitive Function in Older ...
Our preliminary data shows that post-HCT, 35% of older patients experience significant cognitive impairment compared to 19% pre-HCT. Physical activity improves ...
Improving Cognitive Function in Older Adults Undergoing ...
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant (PROACTIVE) ... CHAMPS-II physical activity program adapted to the HCT setting.
Promoting Physical Activity to Improve Cognitive Function in Older ...
Our preliminary data shows that post-HCT, 35% of older patients experience significant cognitive impairment compared to 19% pre-HCT. Physical activity improves ...
4.
withpower.com
withpower.com/trial/phase-multiple-myeloma-6-2021-9abe5?condition=Leukemia&overallStatus=Recruiting&hasNoPlacebo=truePhysical Activity Intervention for Cognitive Function Post-Stem ...
Trial Overview The trial tests an adapted physical activity program called CHAMPS-II, designed to improve cognitive function in seniors post-stem cell ...
5.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT04898790/improving-cognitive-function-in-older-adults-undergoing-stem-cell-transplantImproving Cognitive Function in Older Adults Undergoing ...
Investigators will adapt CHAMPS II, an evidence-based physical activity intervention, to the HCT setting for older adults to improve cognitive ...
Community Healthy Activities Model Program for Seniors ...
This individually tailored, choice-based physical activity program promotes increased long-term physical activity levels in older adults.
RePORT ⟩ RePORTER
We're sorry but RePORTER doesn't work properly without JavaScript enabled. Please enable it to continue.
CHAMPS Physical Activity Questionnaire for Older Adults
This unique program aimed to increase physical activity levels of seniors by encouraging them to participate in physical activities of their choice, based on ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.